For the 2013-2014 academic year, three $50,000 USP Global Fellowship awards have been presented.
Recognized for establishing quality standards for medicines, food ingredients, and dietary supplements, the United States Pharmacopeial Convention (USP) announced the selection of its 2013-2014 USP Global Fellows. The Global Fellowship program has awarded $150,000 in research grants to support the work of early-career scientists with the goal of advancing research priorities in small moleculedrugs, biologics, excipients, dietary supplements, and food ingredients that address specific USP scientific or research needs.
Each year, USP conducts a competitive process for selecting fellows who are engaged in full-time study in a PhD or Pharm. D. program, medical school, or dental school, and whose works are directly relevant to USP’s priorities.
For the 2013-2014 academic year, three $50,000 USP Global Fellowship awards have been presented to the following students:
• Adam L. Kaylor, PhD candidate, Georgia Institute of Technology, School of Chemistry and Biochemistry
Area of Research—Development of a new pulsed plasma ion source for counterfeit drug analyses by portable ion-mobility spectrometry and rapid liquid chromatography-mass spectrometry (LC-MS).
• Haichen Nie, M.S., Purdue University, College of Pharmacy, Department of Industrial and Physical Pharmacy
Area of Research—Sustainable medicines for Africa—Development of monographs and associated knowledge to increase access to HIV/AIDS medicines for resistant infections (Darunavir-Ritonavir).
• Sharla M. Peters, Postdoctoral candidate, Howard University, College of Medicine, Department of Biochemistry and Molecular Biology
Area of Research—Development of a multiplex real-time polymerase chain reaction assay for the detection of ruminant material in adulterated products.
Each of the Global Fellows will communicate regularly with a scientific liaison from USP headquarters in Rockville, Maryland, providing updates on his or her work and the relevance of its progress to USP’s priorities. In addition, each fellow will be invited to give a poster presentation at an USP-sponsored meeting or event during the course of the academic year.
Source: USP
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.